Europe Breast Cancer News
Europe
Europe Breast Cancer News is an EIN News Service for breast cancer professionals. Constantly updated news and information about Europe Breast Cancer.
Latest Europe Breast Cancer News
- Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer 14 Dec 2009 11:55 GMT
... from the American Cancer Society finds the breast cancer death rate in the United States co... Drug ... drug Celsentri to go on sale in Europe. Avastin (bevacizumab), Roche's innovative anti-cancer drug, was ... such as ibuprofen can increase the... Eastern European and Middle Eastern patients with diseased blood ...
- Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Canc 14 Dec 2009 11:51 GMT
... presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS). The first of these studies evaluated ... were previously presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society ... in the United States and 430,000 in Europe each year. More than 40,000 women in ...
- Nexavar in Combination with Chemo... 14 Dec 2009 13:10 GMT
... presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS). The first of these studies evaluated ... were previously presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society ... in the United States and 430,000 in Europe each year. More than 40,000 women in ...
- No More Delay 12/14 14 Dec 2009 17:30 GMT
... good Samaritans in the medical profession. 12/3 Breast Cancer Terror What they don't understand is that this ... flu was very severe in war torn Europe, but there are few details on the ... such as the Italians, Russians, and southern Europeans. It claims that 500,000 died in the ...
- Jewish women in Ontario offered free genetic test to prevent cancer 14 Dec 2009 21:37 GMT
... with or without a family history of breast cancer – to come forward for testing in May ... a group with mainly Central and Eastern European ancestry, are at increased risk. Some studies ... four founding mothers, who lived somewhere in Europe within the past 2,000 years. The test ...
- December 2009 (26) 14 Dec 2009 16:35 GMT
... wants to allow prescription medications from Canada, Europe, and elsewhere that could represent billions in ... opioids to avoid overdose and death. The European Union is issuing a warning to parents ... countries. Young women with a high-risk of breast cancer may want to pay attention to the latest ...
- French and Benelux stocks - Factors to watch on Dec 14 14 Dec 2009 06:14 GMT
... fields, its chief executive said on Saturday. European aerospace group EADS wants to use takeovers ... Stream gas pipeline bringing Russian gas to Europe and there could be other partners, one ... U.S. regulators will review its BSI-201 experimental breast cancer drug on an accelerated basis and that a ...
- Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 St 11 Dec 2009 22:12 GMT
... Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies WAYNE, N.J. and ... were previously presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society ... in the United States and 430,000 in Europe each year. More than 40,000 women in ...
- Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 11 Dec 2009 22:11 GMT
... presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS). The first of these studies evaluated ... were previously presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society ... in the United States and 430,000 in Europe each year. More than 40,000 women in ...
- Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies / - Data Presented at 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium - 11 Dec 2009 22:15 GMT
... presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS). The first of these studies evaluated ... were previously presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society ... in the United States and 430,000 in Europe each year. More than 40,000 women in ...
- Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies (PRN) 11 Dec 2009 22:15 GMT
... potential as a combination therapy for advanced breast cancer patients in both the first and second-line setting," ... were previously presented at the joint 15th European Society for Medical Oncology (ESMO) Multidisciplinary Congress ... in the United States and 430,000 in Europe each year. More than 40,000 women in ...
- GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 11 Dec 2009 19:11 GMT
... Month Overall Survival in Patients with Advanced Breast Cancer LONDON and PHILADELPHIA, Dec. 11 /PRNewswire/ -- In ... of the GlaxoSmithKline group of companies in Europe. XELODA® is a registered trademark of Roche ... 483 2839 Sarah Alspach (919) 483 2839 European Analyst/Investor Enquiries: David Mawdsley (020) 8047 5564 ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10 Dec 2009 11:50 GMT
... 10 pharma company in the U.S., major Europe and globally. R&D pipeline boasts more than ... a global Phase III study in first-line breast cancer is ongoing, and a second Phase III ... cancers and additional studies in colorectal and breast cancers. This is in addition to Phase II ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance (PRN) 10 Dec 2009 11:54 GMT
... growing in the United States and major Europe; the fourth-fastest growing in the pharmerging markets; ... a global Phase III study in first-line breast cancer is ongoing, and a second Phase III ... cancers and additional studies in colorectal and breast cancers. This is in addition to Phase II ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 10 Dec 2009 11:57 GMT
... 10 pharma company in the U.S., major Europe and globally. -- R&D pipeline boasts more ... a global Phase III study in first-line breast cancer is ongoing, and a second Phase III ... cancers and additional studies in colorectal and breast cancers. This is in addition to Phase II ...
- Lilly Outlines Innovation Strategy and Sets 2010 Financial Guidance 10 Dec 2009 13:33 GMT
... growing in the United States and major Europe; the fourth-fastest growing in the pharmerging markets; ...       first-line breast cancer is ongoing, and a second Phase III ...    studies in colorectal and breast cancers. This is in addition to Phase  ...
- Lilly Outlines Innovation Strategy 10 Dec 2009 15:12 GMT
... 10 pharma company in the U.S., major Europe and globally. * R&D pipeline boasts more ... a global Phase III study in first-line breast cancer is ongoing, and a second Phase III ... cancers and additional studies in colorectal and breast cancers. This is in addition to Phase II ...
- Lilly (Eli) & Co Lilly Outlines Innovation Strategy 10 Dec 2009 15:40 GMT
... 10 pharma company in the U.S., major Europe and globally. * R&D pipeline boasts more ... a global Phase III study in first-line breast cancer is ongoing, and a second Phase III ... cancers and additional studies in colorectal and breast cancers. This is in addition to Phase II ...
- Promising Results Reported in Cell-Enriched Breast Reconstruction Trial 12 Dec 2009 13:33 GMT
... Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched ... at the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (Poster #4123) by Dr. Eva Weiler-Mithoff, M.D., ... in 2007 and is commercially available in Europe and certain other markets. More information on ...
- Novartis set to sustain its leading global position in oncology with portfolio targeting various tum 12 Dec 2009 18:11 GMT
... with 16 new molecular entities o Two US/EU oncology submissions on track for end-2009: Tasigna ... form of CML and Zometa in adjuvant breast cancer patients o Up to five regulatory submissions planned ... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ...
- Novartis set to sustain its leading global position in oncology with portfolio targeting various tumors and life-threatening diseases 9 Dec 2009 14:11 GMT
... with 16 new molecular entities * Two US/EU oncology submissions on track for end-2009: Tasigna ... form of CML and Zometa in adjuvant breast cancer patients * Up to five regulatory submissions planned ... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ...
- Novartis Set to Sustain Its Leading Global Position In Oncology With Portfolio Targeting Various Tumors and Life-Threatening Diseases 9 Dec 2009 15:33 GMT
... with 16 new molecular entities * Two US/EU oncology submissions on track for end-2009: Tasigna ... form of CML and Zometa in adjuvant breast cancer patients * Up to five regulatory submissions planned ... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ...
- Novartis Seeks To Broaden Use Of Some Cancer Drugs 9 Dec 2009 07:12 GMT
... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ... planned to be submitted for US and EU approval for adjuvant use in certain types ... use in certain types of patients with breast cancer based on results from the Austrian Breast & ...
- Novartis set to sustain its leadi... 9 Dec 2009 13:50 GMT
... of market exclusivity for Diovan (hypertension) in Europe (2011) and the US (2012). "We have a productive ... planned to be submitted for US and EU approval for adjuvant use in certain types ... use in certain types of patients with breast cancer based on results from the Austrian Breast & ...
- Promising Results Reported in Cell-Enriched Breast Reconstruction Trial 12 Dec 2009 13:30 GMT
... SAN ANTONIO--(BUSINESS WIRE)-- Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched ... at the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (Poster #4123) by Dr. Eva Weiler-Mithoff, M.D., ... in 2007 and is commercially available in Europe and certain other markets. More information on ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
healthday.com:
ap.org:
themedguru.com:
stv.tv: